Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Shares Outstanding (Weighted Average) (2018 - 2025)

Neurogene (NGNE) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $21.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 24.46% year-over-year to $21.1 million, compared with a TTM value of $21.1 million through Sep 2025, up 24.46%, and an annual FY2024 reading of $17.6 million, changed N/A over the prior year.
  • Shares Outstanding (Weighted Average) was $21.1 million for Q3 2025 at Neurogene, roughly flat from $21.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $21.1 million in Q3 2025 and bottomed at $16.9 million in Q1 2024.